2023 Keynote Address

Nicole (Nikki) Goodwin received a B.S. with honors in chemistry from the University of Delaware where a two year undergraduate research experience with Doug Taber cemented her interested in organic chemistry. She subsequently earned her Ph.D. from Caltech working with Dave MacMillan on the development of novel organocatalytic strategies. After graduation, Nicole started her industrial career as a medicinal chemist at Lexicon Pharmaceuticals in Princeton, NJ where she most notably was an team member and inventor of Zynquista™ (sotagliflozin) for the treatment of diabetes. In 2014, Nicole transitioned from the biotech sector to big pharma with a move to GlaxoSmithKline where she is currently a director in the Discovery High-Throughput Chemistry Group in Medicinal Chemistry in Collegeville, PA. Over the course of her career, Nicole has worked in a variety of therapeutic areas, including metabolic diseases, ophthalmology, immunology, and respiratory. She is an active member of the American Chemical Society and has a passion for driving science through industrial/academic collaborations. Nicole grew up in southern New Jersey outside of Philadelphia and enjoys spending her spare time at the gym, cycling, cooking, and travelling.